CPDP1

Across TCGA pan-cancer cohorts, CPDP1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated CPDP1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CPDP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CPDP1 expression acts as an unfavorable survival marker.

KIRP, UCS, and HNSC are the cancer types where CPDP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.119	0.695	<.001	123	view →
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →
HNSC	OS	Tertile	II,III,IV	0.051	0.712	<.001	72	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
PAAD	OS	Tertile	All	0.132	0.613	.002	45	view →
UCEC	DFS	Tertile	All	0.100	0.646	.024	36	view →
KIRC	DFS	Tertile	III,IV	0.138	0.486	.029	24	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

CPDP1–KIRP (OS)

Open the KIRP breakdown →